A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/39 (2006.01) A61K 48/00 (2006.01) C07K 14/575 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2183260
The present invention relates to a composition for enhancing the immune response of an animal to an infectious disease vaccine wherein the composition comprises prolactin. Preferably, the composition is human prolactin and the animal to be vaccinated is, as well, human. The present invention further relates to a composition for enhancing the immune response of an animal to an infectious disease vaccine wherein the composition comprises prolactin cDNA. Human prolactin cDNA is preferred.
Cette invention se rapporte à une composition destinée à accroître la réponse immunitaire d'un animal à un vaccin de maladie infectieuse, ladite composition comprenant de la prolactine. Cette composition est de préférence de la prolactine humaine et l'animal à vacciner est également de préférence l'homme. Cette invention serapporte en outre à une composition destinée à accroître la réponse immunitaire d'un animal à un vaccin de maladie infectieuse, cette composition comprenant de l'ADNc de prolactine. De l'ADNc de prolactine humaine est préféré.
Kaplan Johanne
Moscicki Richard
Richards Susan
Genzyme Corporation
Smart & Biggar
LandOfFree
Prolactin as a vaccine adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prolactin as a vaccine adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prolactin as a vaccine adjuvant will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2062299